Article Listing - Unprecedented survival results for B-MS Yervoy and Roche’s vemurafenib in melanoma discussed at ASCO

NEG LIST TALKS CONTINUE IN SPAIN

27 April 1992

Talks are continuing between the Spanish Health Ministry and the Spanish pharmaceutical industry association, Farmaindustria, on the selective financing of...

UPJOHN'S GLYNASE APPROVED IN USA

27 April 1992

Upjohn has received marketing approval from the US Food and Drug Administration for an improved formulation of its leading antidiabetic...

IVAX CORP ACQUIRES WAVERLEY PHARMA

27 April 1992

US-based Ivax Corporation has acquired the British company Waverley Pharmaceutical for around L 22 million ($38.5 million) in stock. The...

BAYER'S CIPROXIN & UTIs

27 April 1992

Prophylaxis with Bayer's quinolone antibiotic Ciproxin (ciprofloxacin) is effective and safe in the prevention of catheter-associated urinary tract-infection and related...

BELMAC EUROPE LAUNCHES EPO PRODS

27 April 1992

Belmac Europe has launched three oral powder formulations of erythromycin, under the trade name Biolid, onto the French market. The...

US DEBARMENT BILL LEGISLATION LIKELY

27 April 1992

Some form of legislation seems to be on the cards now the US Senate has passed the Generic Drug Industry...

"STRINGS" WITH US ACCELERATED APPRO

27 April 1992

The accelerated approval proposal which the US Food and Drug Administration published this month changes the set of principles which...

A L LABS TO COMBINE WITH OSLO COMPANY

27 April 1992

The US pharmaceutical concern A L Laboratories has announced that it is studying the desirability and feasibility of combining some...

Japan FTC To Reduce Antitrust Exemptions

27 April 1992

Moves to reduce exemptions from the Antimonopoly Law, by halving the number of products eligible for a system that allows...

ISRAEL'S TEVA BUYING HUNGARIAN FIRM

27 April 1992

According to press reports confirmed by senior executives at Israeli drugmaker Teva, the company is at an advanced stage of...

Showing 94141-94150 of 95372 articles